ClinicalTrials.gg
CompletedNCT07948460Updated Nov 19, 2026

Headache and Nasal Dysfunction in Children

An observational study in Headache and Nasal Airway, sponsored by Adana City Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 5 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Adana City Training and Research Hospital · Observational

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,323
Ages
5 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 64 studies in Headache with a site in Turkey — 9 open to participants now, 10 under way, none of them phase 3. Headache · Turkey.

Enrollment
Largest of 28
1,323 · median 141
Started
2026
with 4 others
Observational
28 of 64
4 open now
Registered
64th of 64
by date

Among the 64 studies in Headache with a site in Turkey, this one has the largest enrollment of the 28 observational ones that give a count, is one of 5 that started in 2026, is one of 28 observational ones, and was the 64th registered.

Headache

764 studies on the registry are indexed under Headache; 134 are open to participants now.

Browse Headache studies →

Open to participants now

9 of the 64 studies in Headache with a site in Turkey are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 83 Headache studies recruiting now, 30 (36%) set no upper age limit and 44 (53%) stop at 75 or younger; 10 take children under 18; 14 take healthy volunteers.

This study: 5 Years to 10 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 64 studies in Headache with a site in Turkey, or all of them as a file.
02

Study summary

Headaches in pediatric patients can be related to primary (essential) and secondary (symptomatic) causes. This study investigates the correlation between nasal dysfunction, specifically mucociliary clearance impairment and structural anomalies, and cephalalgia in children, with a focus on allergic rhinitis and rhinopathy. A total of 2,262 children aged 5 to 10 years were screened. Clinical evaluation included evaluation of headache history, nasal patency, mucociliary clearance function, and the presence of structural anomalies such as septal deviation or adenoidal hypertrophy. A significant association was found between nasal dysfunction and headache. Children with impaired mucociliary clearance, nasal obstruction, or structural abnormalities demonstrated a higher prevalence of cephalalgia compared to those with normal nasal function. Allergic rhinitis was frequently observed among patients who reported recurrent headaches. Altered nasal dysfunction appears to be an important and potentially underrecognized contributor to pediatric headache. These findings highlight the need for comprehensive Ear Nose Throat evaluation in children with recurrent and unexplained cephalalgia.

03

Conditions studied

  • Headache
  • Nasal Airway

Keywords

  • headache
  • child
  • mucociliary clearance
  • allergic rhinitis
  • adenoids
04

Who can participate

Ages eligible
5 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Among the enrolled participants, 126 children reported recurrent headache episodes and constituted the cephalalgia group, whereas the remaining 1,197 children served as the control group.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 5-10 years
  • Children who underwent clinical evaluation for recurrent headache or were included in the control group
  • Availability of relevant clinical and laboratory data in the medical records

Exclusion criteria

Exclusion Criteria:

  • Incomplete medical records
  • Missing data regarding the primary study variables
  • Medical conditions that could significantly affect the assessment of sinonasal function or headache
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,323 participants (actual)
Target follow-up
3 Months
Patient registry
Yes

Groups and cohorts

  • group 1

    recurrent headache

  • group 2

    control

06

What researchers measure

Primary outcomes

  1. nasal airway conductance

    Nasal airflow was assessed by active anterior rhinomanometry using a Rhino-Comp 4000 rhinomanometer (Homoth Medizinelektronik GmbH \& Co. KG, Hamburg, Germany). Nasal conductance was calculated as the ratio of nasal airflow to transnasal pressure and expressed in liters per minute per millimeter of water pressure (L/min/mmH₂O) for both nasal cavities.

    Time frame: At the initial clinical assessment (baseline)

07

Study locations

1 site
  • Adana City Training and Research Hospital
    Adana, Yuregir 01370, Turkey (Türkiye)
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be publicly shared due to patient confidentiality, privacy considerations, and the inclusion of data from pediatric participants.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2026 to primary completion in Jan 2026, 0 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 19, 2026
StartActual
Jan 1, 2026
Primary completionActual
Jan 1, 2026
CompletionActual
Mar 1, 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07948460
Lead sponsor
Adana City Training and Research Hospital
Responsible party
Sidika Deniz Yalim (Assoc.Prof.Dr., Adana City Training and Research Hospital) — Principal investigator
First posted
Nov 19, 2026
Start date
Jan 1, 2026
Primary completion
Jan 1, 2026
Completion
Mar 1, 2026
Last update
Nov 19, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion